Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is a critical lipid kinase that regulates the endosomal and lysosomal system by synthesizing phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) from phosphatidylinositol 3-phosphate (PI3P). It plays a central role in membrane homeostasis, endosomal maturation, and autophagy, ensuring the proper trafficking of cargo between endosomes and lysosomes. PIKfyve has emerged as a significant therapeutic target in oncology, particularly for B-cell non-Hodgkin lymphoma, where its inhibition leads to catastrophic lysosomal dysfunction and cell death. Additionally, it is a key host factor for the entry of several viruses, including Ebola, Marburg, and SARS-CoV-2, as its activity is required for viral fusion and genome release from endosomes. Small molecule inhibitors like apilimod, which was initially developed for autoimmune diseases before its target was identified as PIKfyve, are being explored for their antiviral and anticancer potential.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve).